Indirect evidence has been adduced that insulin-binding antibodies in man, formed in response to treatment with commercial mixtures of beefpork insulin, react also with human insulin (1) . Thus, human insulin inhibits competitively the binding of I131-labeled beef, pork, sheep or horse insulin to antibeef-pork insulin antibodies. However, the observation that much higher concentrations of human insulin than of animal insulins may be required to effect a comparable reduction in the binding of animal insulin-I13' suggests that the reaction with human insulin is, in such cases, considerably weaker than with animal insulins (1) . The failure to detect reaction with human insulin in some studies (2) may be interpreted (1) on this basis. It also appears likely that these quantitative relationships may explain why certain diabetic subjects can exhibit a moderate degree of resistance to animal insulins and yet maintain fairly good control of blood sugar through stimulation of their own endogenous insulin secretion in the absence of exogenously administered insulin (3) .
In order to study the reaction of human insulin with antibody in a direct manner, the use of I13'-labeled human insulin is mandatory. Since pure crystalline human insulin is not generally available,' a crude preparation must serve as starting material. The purposes of this communication are to describe the preparation and purification of human insulin-I13', to demonstrate its reaction with human antibodies against beef-pork insulin and to consider the clinical implications of such reaction.
METHODS
All serums were taken at least 24 hours after the last dose of insulin and were allowed to remain at 4°C for at least 2 months to permit destruction by plasma (3) I"31 by methods described previously (5) . Carrier-I' was added in amounts not exceeding a ratio of 0.2 iodine atom per insulin monomer (mol wt 6,000) in the final labeled mixture. After dialysis against distilled water at 4°C to remove unbound iodine, human serum albumin was added to a concentration of 2 per cent and the solutions kept frozen until used.
All preparations and fractions obtained during the purification procedure were analyzed by paper chromatography3 and electrophoresis. It has previously been 2 Purified on cellulose ion-exchange columns by the method of Dr. J. F. Smith, Cambridge, England (6) . 3 During this procedure, the strips are also subjected to electrophoresis, but the principal separation of pro- control human plasma and passed through the column. The original effluent and several washes with veronal buffer were monitored for radioactivity; when radioactivity in the wash had been reduced to a negligible level, the residual adsorbed I13"-labeled material was eluted with several aliquots of whole control plasma, previously treated with iodoacetamide as described below.
The principle of separation of insulin-I131 from other I"'3-labeled compounds in the mixture depends on the capacity of the cellulose to adsorb small amounts of insulin preferentially in the presence of limited amounts of plasma and the ability of high concentrations of plasma to elute the adsorbed insulin-I13l.4 Since the insulinadsorbing capacity of the cellulose is limited, use of large amounts of insulin results in a considerable fraction beteins from the site of application is a result of hydrodynamic flow chromatography rather than electrophoresis (8) .
ing lost with the original effluent. If the total amount passed through the column does not exceed 1 to 2 /sg, approximately 20 to 50 per cent or more is adsorbed by the column, whereas contaminants and damaged fractions which bind to or migrate with plasma proteins on paper strips pass through the column with the original effluent and veronal washes. One ml plasma will generally elute about 20 to 30 per cent of the adsorbed radioactivity.
However, plasma itself, especially at 370 C and after extended periods of incubation even at 40 C, can damage insulin (8) . Since the chromatographic and electrophoretic characteristics of such damaged insulin resemble, in many respects, insulin altered by cysteine or irradiation (9), both of which are known to effect reductive splitting of disulfide bonds (10, 11) , it seemed possible that free sulfhydryl groups in plasma (sulfhydryl groups of serum proteins, free cysteine, reduced glutathione, and so forth) might be responsible in part for "plasma damage" to insulin-I"3'. This hypothesis was tested by treating control plasma with 0.5 per cent iodoacetate or iodoacetamide (30 minutes at 370 C) prior to incubation with insulin-I13". This treatment was effective to a large extent in protecting crystalline beef insulin-I131 against damage by plasma.5 Accordingly, plasma used for elution of insulin-I1"1 was first treated with iodoacetamide as indicated.
RESULTS
A typical purification experiment is summarized in Table I . Scans of radioactivity on paper chromatoelectrophoretograms and electrophoretograms of the unpurified solution, the original effluent and plasma eluates 1 and 2 are shown in Figure 1 . In all preparations (13 separate iodination procedures) the fraction of radioactivity in the unpurified solutions that migrated with the serum proteins on chromatography was about 35 + 5 per cent of the total protein-bound J131. On electrophoresis (Figure 1) as virtually all the iodide'13 not removed by dialysis. Adsorbed radioactivity eluted with plasma contained 2 to 6 per cent migrating components. Evidence that the fraction remaining at the origin (in control plasma) is largely, if not entirely, insulin-I131 is provided by experiments with specific insulin antiserums. When tracer quantities of the purified I13'-labeled human insulin were incubated with guinea pig antibeef insulin or antipork insulin serums or with human antibeef-pork insulin serums containing high concentrations of insulin-binding antibodies, at least 80 to 90 per cent of the adsorbed radioactivity was bound to antibody ( Figure 2 ). This is true also of the adsorbed radioactivity in the unpurified preparations. It is possible that even higher fractions were bound to antibody in the test tubes and that dissociation of the insulin-antibody complexes during migration resulted in the observed trailing of 10 to 20 per cent. In support of this suggestion is the observation that the percentage remaining at the origin and trailing up to the antibody region is greater in the electrophoretograms run over an 18 hour period than in the short-run (30 to 60 minutes) chromatoelectrophoretograms, the longer time required in the former procedure allowing for greater dissociation. On the other hand, in similar experiments with beef insulin-I'31, 99 per cent or more of the radioactivity is demonstrably bound to antibody in both chromatoelectrophoretograms and electrophoretograms. Since generally about 65 per cent of total protein-bound-I'13 in the unpurified solution is adsorbed by paper in the presence of control serum, these results indicate that approximately 50 to 60 per cent of the protein-bound-I'13 in the unpurified preparation represents insulin-I'1 . Since insulin comprises only 27 per cent by weight of the preparation used for iodination, it can be concluded that one-half or more of the non-insulin contaminants is either not able to be iodinated under these conditions, is iodinated less readily than insulin itself, or is dialyzable.
To evaluate quantitative differences between the reaction of human and beef insulin with antibody, antiserums from eight insulin-treated diabetic subjects were incubated for 15 minutes at 370 C with mixtures of human insulin-I'13 and * Determined with diluted antiserum and higher insulin concentrations at equilibrium (after prolonged incubation).
t Corrected for damaged insulin-I113 and assuming that only 85% of adsorbed human insulin-I'3l was available for binding to antibody.
unlabeled Fisher human insulin or beef insulin-I"13 and unlabeled beef insulin at total insulin concentrations of 0.25, 1.0, or 3.0 U per L, and then applied to paper strips in a cold room (40 C) for paper chromatoelectrophoresis. Of the eight antiserums studied (Table II) , three (Lo, Gru, Ge) were from patients who were quite definitely insulin-resistant and had insulin-binding capacities ranging from 97 to 250 U per L; one was from a patient (Gal) who could probably be termed mildly resistant and had a binding capacity of 28 U per L, and one was from a subject (H.L.) reported previously (3) who had an insulin-binding capacity of 22 U per L. The lowest of the concentrations used (0.25 U per L) is in the range of values of endogenous insulin found in normal subjects and in patients with early maturity-onset diabetes, 0.5 to 2 hours after oral administration of 100 g glucose (5); the second concentration used (1 U per L) is at the upper limits of the range of values observed after heavier glucose loading. The highest concentration employed (3 U per L) is considerably beyond the range of endogenous insulin concentrations that we have observed in man (5), but is certainly frequently exceeded in insulin-resistant subjects given large therapeutic doses of insulin.
In almost all cases. more beef insulin than human insulin was bound at the same insulin concentration by the same antiserum ( Figure 3 , Table II ) but in some cases the differences were small after correction for the fraction of radioactivity presumed unavailable for binding to antibody. However, in several subjects (M.N., H.L. and Ge) the binding of human insulin was significantly lower than the binding of beef insulin at the same concentration. In all subjects the concentrations employed were generally far below the maximal binding capacities of the antiserums so that frequently most of the insulin was bound. At higher concentrations more marked differences might have become evident. 1. The preparation of I131-labeled human insulin from a lot of human insulin containing approximately 25 per cent insulin by weight and its purification from labeled contaminants are described.
2. The reaction of human insulin-I131 with insulin-binding antibodies in the serums of human subjects treated with commercial mixtures of animal insulins is demonstrated directly.
3. Comparison of the binding of human insulin and beef insulin in antiserums from eight insulinresistant and nonresistant diabetic subjects revealed a lesser affinity of antibody for human than for beef insulin in most cases, but considerable variability in this respect was encountered among different antiserums. 6 Allergy to insulin is an expression of reaction with sensitizing antibody (13) , an antibody quite distinct from "blocking" antibody (13) and the insulin-binding antibody reported here (14) .
